RecruitingNot ApplicableNCT06492785

Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer

Use of Hyaluronic Acid-enriched Transfer Medium in Women Undergoing Single Blastocyst Transfer : a Multicenter, Randomized Controlled Trial

Sponsor

Northwest Women's and Children's Hospital, Xi'an, Shaanxi

Enrollment

858 participants

Start Date

Sep 13, 2024

Study Type

INTERVENTIONAL

Conditions

Infertility

Summary

The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called High Hyaluronic Acid concentrations (0.5 mg/ml) and a biological treatment called Low Hyaluronic Acid concentrations (0.125 mg/ml) for people with infertility. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.